SUV39H1 and leukemia: Furthermore, restoration of Hoxb13 in SUV-OE AML cells accelerated the leukemia progression and increased the number of LSCs, suggesting Hoxb13 is a downstream effector of Suv39h1 in MA9 leukemia cells.